Trials / Not Yet Recruiting
Not Yet RecruitingNCT05507840
Photobiomodulation for Dry Age Related Macula Degeneration
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 121 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The study will investigate the effect of photobiomodulation treatment on the risk of developing late age related macula degeneration (AMD) in the study eye in patients with wet AMD in the fellow eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Valeda machine | Photobiomodulation treatment with Valeda machine will be applied every six months for 2 years in patients with dry age related macula degeneration. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2022-08-19
- Last updated
- 2022-10-12
Source: ClinicalTrials.gov record NCT05507840. Inclusion in this directory is not an endorsement.